SCHEMBL30412232

SCHEMBL30412232

CCc1cc2c(cc1Nc1ncc(C(F)(F)F)c(Cl)n1)CN(C(=O)C(F)(F)F)CC2

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MERTK Q12866 7/20 0.43
▸ TYRO3 Q06418 7/20 0.43
▸ AXL P30530 5/20 0.43
▸ MAP4K1 Q92918 1/20 0.43
▸ EGFR P00533 1/20 0.43
▸ CHEK1 O14757 6/20 0.42
▸ FLT3 P36888 6/20 0.42
▸ KIT P10721 3/20 0.42
▸ ESR1 P03372 2/20 0.41
▸ ESR2 Q92731 2/20 0.41
▸ BTK Q06187 1/20 0.41
▸ PTK2 Q05397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25204972 1.00 MERTK (0.43) MERTKTYRO3AXLMAP4K1EGFR
SCHEMBL30411174 1.00 MERTK (0.43) MERTKTYRO3AXLMAP4K1EGFR
SCHEMBL25205416 1.00 MERTK (0.43) MERTKTYRO3AXLMAP4K1EGFR
SCHEMBL30411785 0.94 LRRK2 (0.42) MERTKTYRO3AXLMAP4K1CHEK1
SCHEMBL25205942 0.94 LRRK2 (0.42) MERTKTYRO3AXLMAP4K1CHEK1
SCHEMBL25206869 0.89 BTK (0.47) MERTKTYRO3AXLMAP4K1EGFR
SCHEMBL30412572 0.89 BTK (0.47) MERTKTYRO3AXLMAP4K1EGFR
SCHEMBL25199628 0.89 MERTK (0.46) MERTKTYRO3AXLMAP4K1EGFR
SCHEMBL25202712 0.89 MERTK (0.46) MERTKTYRO3AXLMAP4K1EGFR
SCHEMBL30412120 0.89 MERTK (0.46) MERTKTYRO3AXLMAP4K1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4433059-A1 THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF Erasca, Inc. (US) 2024-09-25 — — EP disclosed
WO-2023215494-A1 THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF ERASCA, INC. (US) 2023-11-09 — — WO disclosed
WO-2023087027-A1 THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF ERASCA, INC. (US) 2023-05-19 — — WO disclosed
Send feedback